STOCK TITAN

TWST stock (NASDAQ: TWST) holder plans 5,000-share sale filing

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

A shareholder of TWST plans to sell 5,000 shares of common stock through Fidelity Brokerage Services for an aggregate market value of $249,650.00, with an approximate sale date of February 11, 2026 on the NASDAQ exchange.

The filing notes that 61,311,704 shares of this class were outstanding. It also lists recent sales by Dennis H. Cho, including 1,099 common shares sold on February 3, 2026 for gross proceeds of $51,186.47, alongside three earlier sales in November and December 2025.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

How many TWST shares are planned for sale in this notice?

The notice covers a planned sale of 5,000 shares of TWST common stock. These shares are to be sold through Fidelity Brokerage Services LLC with an aggregate market value of $249,650.00, and the approximate sale date disclosed is February 11, 2026 on NASDAQ.

When and how were the TWST shares to be sold originally acquired?

The 5,000 TWST common shares were acquired on May 10, 2023 via an open market purchase from the issuer. The table shows that the full amount of 5,000 shares was paid for on the same date, and the consideration was described as cash.

What recent TWST share sales by Dennis H. Cho are disclosed?

The disclosure lists four TWST common stock sales by Dennis H. Cho: 757 shares on November 21, 2025, 398 shares on December 8, 2025, 324 shares on December 22, 2025, and 1,099 shares on February 3, 2026, each with stated gross proceeds.

How many TWST common shares were outstanding according to the filing?

The filing states that 61,311,704 shares of the relevant TWST common stock class were outstanding. This figure provides context for the planned 5,000-share sale, showing the relative size of the transaction compared with the total outstanding share count at that time.

On which exchange will the TWST shares be sold and through which broker?

The planned 5,000-share sale of TWST common stock is listed for the NASDAQ securities exchange. The broker named is Fidelity Brokerage Services LLC, located at 900 Salem Street, Smithfield, Rhode Island, which is designated to handle the transaction under this notice.

What representation does the seller make about material nonpublic information on TWST?

By signing, the person for whose account the TWST securities are to be sold represents that they do not know any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed, as explicitly stated in the signature section language.

What does the filing say about Rule 10b5-1 trading plans for TWST shares?

The document explains that if a written trading plan or instruction under Rule 10b5-1 is used, the signer represents the same lack of undisclosed material adverse information as of the plan adoption or instruction date. A column is provided to show such a date when applicable.
Twist Bioscience

NASDAQ:TWST

TWST Rankings

TWST Latest News

TWST Latest SEC Filings

TWST Stock Data

3.01B
60.34M
1.86%
115.89%
16.96%
Diagnostics & Research
Biological Products, (no Disgnostic Substances)
Link
United States
SOUTH SAN FRANCISCO